Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ALNY
BIIB
Add up to 3 more stocks
ALNY
Alnylam Pharmaceuticals, Inc.
+0.13%
$279.50+0.35
Market Cap
$37.32B
52W Range
$273.11 - $495.55
BIIB
Biogen Inc.
+5.99%
$209.05+11.81
Market Cap
$30.86B
52W Range
$121.05 - $219.72
| Metric | ALNY | BIIB |
|---|---|---|
| Valuation | ||
| P/E Ratio | 66.30 | 21.12 |
| Forward P/E | 37.62 | 14.28 |
| P/B Ratio | 35.88 | 1.57 |
| P/S Ratio | 9.00 | 2.97 |
| P/FCF Ratio | 60.16 | 11.16 |
| PEG Ratio | - | - |
| EV/EBITDA | 47.27 | 13.35 |
| Profitability | ||
| Gross Margin | 80.9% | 69.8% |
| Operating Margin | 17.5% | 15.7% |
| Net Margin | 13.5% | 13.9% |
| ROE | 53.7% | 7.4% |
| ROA | 11.3% | 4.7% |
| ROIC | 13.7% | 6.6% |
| Financial Health | ||
| Current Ratio | 2.76 | 2.68 |
| Quick Ratio | 2.71 | 2.03 |
| Debt/Equity | 1.62 | 0.38 |
| Interest Coverage | 1.99 | 7.63 |
| Dividends | ||
| Dividend Yield | - | - |
| Payout Ratio | - | - |
| Consecutive Div Years | 0 | 0 |